Consumer Goods
Global Non-prescription Mouthrinse Market Research Report 2025
- Apr 07, 25
- ID: 166727
- Pages: 99
- Figures: 105
- Views: 4
The global market for Non-prescription Mouthrinse was valued at US$ 2138 million in the year 2024 and is projected to reach a revised size of US$ 3323 million by 2031, growing at a CAGR of 6.6% during the forecast period.
The non-prescription mouthwash market, also known as non-prescription oral rinse, encompasses a range of oral care products that are designed for daily use and do not require a prescription. These mouth rinses are commonly used for maintaining oral hygiene, freshening breath, and promoting overall oral health.
The non-prescription mouthwash market has been growing steadily in recent years, driven by factors such as increasing awareness of oral health, a rise in disposable income, and the growing emphasis on personal grooming and hygiene.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Non-prescription Mouthrinse, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-prescription Mouthrinse.
The Non-prescription Mouthrinse market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Non-prescription Mouthrinse market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Non-prescription Mouthrinse manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Johnson & Johnson
Sunstar
P&G
Lion
Colgate-Palmolive
Unilever
Church & Dwight
PIERAS CO
GSK
Caldwell Consumer Health
Weleda
Dentyl Active
Kao Corporation
NYSCPS
WEIMEIZI (GUANGDONG) CO.
Reckitt Benckiser Group Plc
SmartMouth Oral Health Laboratories
Segment by Type
Alcoholic
Non-alcoholic
Segment by Application
Hypermarket and Supermarket
Convenience Stores
Online Sale
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Non-prescription Mouthrinse manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Non-prescription Mouthrinse in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The non-prescription mouthwash market, also known as non-prescription oral rinse, encompasses a range of oral care products that are designed for daily use and do not require a prescription. These mouth rinses are commonly used for maintaining oral hygiene, freshening breath, and promoting overall oral health.
The non-prescription mouthwash market has been growing steadily in recent years, driven by factors such as increasing awareness of oral health, a rise in disposable income, and the growing emphasis on personal grooming and hygiene.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Non-prescription Mouthrinse, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-prescription Mouthrinse.
The Non-prescription Mouthrinse market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Non-prescription Mouthrinse market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Non-prescription Mouthrinse manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Johnson & Johnson
Sunstar
P&G
Lion
Colgate-Palmolive
Unilever
Church & Dwight
PIERAS CO
GSK
Caldwell Consumer Health
Weleda
Dentyl Active
Kao Corporation
NYSCPS
WEIMEIZI (GUANGDONG) CO.
Reckitt Benckiser Group Plc
SmartMouth Oral Health Laboratories
Segment by Type
Alcoholic
Non-alcoholic
Segment by Application
Hypermarket and Supermarket
Convenience Stores
Online Sale
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Non-prescription Mouthrinse manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Non-prescription Mouthrinse in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Non-prescription Mouthrinse Market Overview
1.1 Product Definition
1.2 Non-prescription Mouthrinse by Type
1.2.1 Global Non-prescription Mouthrinse Market Value Comparison by Type (2024 VS 2031)
1.2.2 Alcoholic
1.2.3 Non-alcoholic
1.3 Non-prescription Mouthrinse by Application
1.3.1 Global Non-prescription Mouthrinse Market Value by Application (2024 VS 2031)
1.3.2 Hypermarket and Supermarket
1.3.3 Convenience Stores
1.3.4 Online Sale
1.4 Global Non-prescription Mouthrinse Market Size Estimates and Forecasts
1.4.1 Global Non-prescription Mouthrinse Revenue 2020-2031
1.4.2 Global Non-prescription Mouthrinse Sales 2020-2031
1.4.3 Global Non-prescription Mouthrinse Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Non-prescription Mouthrinse Market Competition by Manufacturers
2.1 Global Non-prescription Mouthrinse Sales Market Share by Manufacturers (2020-2025)
2.2 Global Non-prescription Mouthrinse Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Non-prescription Mouthrinse Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Non-prescription Mouthrinse, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Non-prescription Mouthrinse, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Non-prescription Mouthrinse, Product Type & Application
2.7 Global Key Manufacturers of Non-prescription Mouthrinse, Date of Enter into This Industry
2.8 Global Non-prescription Mouthrinse Market Competitive Situation and Trends
2.8.1 Global Non-prescription Mouthrinse Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Non-prescription Mouthrinse Players Market Share by Revenue
2.8.3 Global Non-prescription Mouthrinse Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Non-prescription Mouthrinse Market Scenario by Region
3.1 Global Non-prescription Mouthrinse Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Non-prescription Mouthrinse Sales by Region: 2020-2031
3.2.1 Global Non-prescription Mouthrinse Sales by Region: 2020-2025
3.2.2 Global Non-prescription Mouthrinse Sales by Region: 2026-2031
3.3 Global Non-prescription Mouthrinse Revenue by Region: 2020-2031
3.3.1 Global Non-prescription Mouthrinse Revenue by Region: 2020-2025
3.3.2 Global Non-prescription Mouthrinse Revenue by Region: 2026-2031
3.4 North America Non-prescription Mouthrinse Market Facts & Figures by Country
3.4.1 North America Non-prescription Mouthrinse Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Non-prescription Mouthrinse Sales by Country (2020-2031)
3.4.3 North America Non-prescription Mouthrinse Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Non-prescription Mouthrinse Market Facts & Figures by Country
3.5.1 Europe Non-prescription Mouthrinse Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Non-prescription Mouthrinse Sales by Country (2020-2031)
3.5.3 Europe Non-prescription Mouthrinse Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Non-prescription Mouthrinse Market Facts & Figures by Region
3.6.1 Asia Pacific Non-prescription Mouthrinse Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Non-prescription Mouthrinse Sales by Region (2020-2031)
3.6.3 Asia Pacific Non-prescription Mouthrinse Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Non-prescription Mouthrinse Market Facts & Figures by Country
3.7.1 Latin America Non-prescription Mouthrinse Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Non-prescription Mouthrinse Sales by Country (2020-2031)
3.7.3 Latin America Non-prescription Mouthrinse Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Non-prescription Mouthrinse Market Facts & Figures by Country
3.8.1 Middle East and Africa Non-prescription Mouthrinse Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Non-prescription Mouthrinse Sales by Country (2020-2031)
3.8.3 Middle East and Africa Non-prescription Mouthrinse Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Non-prescription Mouthrinse Sales by Type (2020-2031)
4.1.1 Global Non-prescription Mouthrinse Sales by Type (2020-2025)
4.1.2 Global Non-prescription Mouthrinse Sales by Type (2026-2031)
4.1.3 Global Non-prescription Mouthrinse Sales Market Share by Type (2020-2031)
4.2 Global Non-prescription Mouthrinse Revenue by Type (2020-2031)
4.2.1 Global Non-prescription Mouthrinse Revenue by Type (2020-2025)
4.2.2 Global Non-prescription Mouthrinse Revenue by Type (2026-2031)
4.2.3 Global Non-prescription Mouthrinse Revenue Market Share by Type (2020-2031)
4.3 Global Non-prescription Mouthrinse Price by Type (2020-2031)
5 Segment by Application
5.1 Global Non-prescription Mouthrinse Sales by Application (2020-2031)
5.1.1 Global Non-prescription Mouthrinse Sales by Application (2020-2025)
5.1.2 Global Non-prescription Mouthrinse Sales by Application (2026-2031)
5.1.3 Global Non-prescription Mouthrinse Sales Market Share by Application (2020-2031)
5.2 Global Non-prescription Mouthrinse Revenue by Application (2020-2031)
5.2.1 Global Non-prescription Mouthrinse Revenue by Application (2020-2025)
5.2.2 Global Non-prescription Mouthrinse Revenue by Application (2026-2031)
5.2.3 Global Non-prescription Mouthrinse Revenue Market Share by Application (2020-2031)
5.3 Global Non-prescription Mouthrinse Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Johnson & Johnson
6.1.1 Johnson & Johnson Company Information
6.1.2 Johnson & Johnson Description and Business Overview
6.1.3 Johnson & Johnson Non-prescription Mouthrinse Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Johnson & Johnson Non-prescription Mouthrinse Product Portfolio
6.1.5 Johnson & Johnson Recent Developments/Updates
6.2 Sunstar
6.2.1 Sunstar Company Information
6.2.2 Sunstar Description and Business Overview
6.2.3 Sunstar Non-prescription Mouthrinse Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Sunstar Non-prescription Mouthrinse Product Portfolio
6.2.5 Sunstar Recent Developments/Updates
6.3 P&G
6.3.1 P&G Company Information
6.3.2 P&G Description and Business Overview
6.3.3 P&G Non-prescription Mouthrinse Sales, Revenue and Gross Margin (2020-2025)
6.3.4 P&G Non-prescription Mouthrinse Product Portfolio
6.3.5 P&G Recent Developments/Updates
6.4 Lion
6.4.1 Lion Company Information
6.4.2 Lion Description and Business Overview
6.4.3 Lion Non-prescription Mouthrinse Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Lion Non-prescription Mouthrinse Product Portfolio
6.4.5 Lion Recent Developments/Updates
6.5 Colgate-Palmolive
6.5.1 Colgate-Palmolive Company Information
6.5.2 Colgate-Palmolive Description and Business Overview
6.5.3 Colgate-Palmolive Non-prescription Mouthrinse Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Colgate-Palmolive Non-prescription Mouthrinse Product Portfolio
6.5.5 Colgate-Palmolive Recent Developments/Updates
6.6 Unilever
6.6.1 Unilever Company Information
6.6.2 Unilever Description and Business Overview
6.6.3 Unilever Non-prescription Mouthrinse Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Unilever Non-prescription Mouthrinse Product Portfolio
6.6.5 Unilever Recent Developments/Updates
6.7 Church & Dwight
6.7.1 Church & Dwight Company Information
6.7.2 Church & Dwight Description and Business Overview
6.7.3 Church & Dwight Non-prescription Mouthrinse Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Church & Dwight Non-prescription Mouthrinse Product Portfolio
6.7.5 Church & Dwight Recent Developments/Updates
6.8 PIERAS CO
6.8.1 PIERAS CO Company Information
6.8.2 PIERAS CO Description and Business Overview
6.8.3 PIERAS CO Non-prescription Mouthrinse Sales, Revenue and Gross Margin (2020-2025)
6.8.4 PIERAS CO Non-prescription Mouthrinse Product Portfolio
6.8.5 PIERAS CO Recent Developments/Updates
6.9 GSK
6.9.1 GSK Company Information
6.9.2 GSK Description and Business Overview
6.9.3 GSK Non-prescription Mouthrinse Sales, Revenue and Gross Margin (2020-2025)
6.9.4 GSK Non-prescription Mouthrinse Product Portfolio
6.9.5 GSK Recent Developments/Updates
6.10 Caldwell Consumer Health
6.10.1 Caldwell Consumer Health Company Information
6.10.2 Caldwell Consumer Health Description and Business Overview
6.10.3 Caldwell Consumer Health Non-prescription Mouthrinse Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Caldwell Consumer Health Non-prescription Mouthrinse Product Portfolio
6.10.5 Caldwell Consumer Health Recent Developments/Updates
6.11 Weleda
6.11.1 Weleda Company Information
6.11.2 Weleda Description and Business Overview
6.11.3 Weleda Non-prescription Mouthrinse Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Weleda Non-prescription Mouthrinse Product Portfolio
6.11.5 Weleda Recent Developments/Updates
6.12 Dentyl Active
6.12.1 Dentyl Active Company Information
6.12.2 Dentyl Active Description and Business Overview
6.12.3 Dentyl Active Non-prescription Mouthrinse Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Dentyl Active Non-prescription Mouthrinse Product Portfolio
6.12.5 Dentyl Active Recent Developments/Updates
6.13 Kao Corporation
6.13.1 Kao Corporation Company Information
6.13.2 Kao Corporation Description and Business Overview
6.13.3 Kao Corporation Non-prescription Mouthrinse Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Kao Corporation Non-prescription Mouthrinse Product Portfolio
6.13.5 Kao Corporation Recent Developments/Updates
6.14 NYSCPS
6.14.1 NYSCPS Company Information
6.14.2 NYSCPS Description and Business Overview
6.14.3 NYSCPS Non-prescription Mouthrinse Sales, Revenue and Gross Margin (2020-2025)
6.14.4 NYSCPS Non-prescription Mouthrinse Product Portfolio
6.14.5 NYSCPS Recent Developments/Updates
6.15 WEIMEIZI (GUANGDONG) CO.
6.15.1 WEIMEIZI (GUANGDONG) CO. Company Information
6.15.2 WEIMEIZI (GUANGDONG) CO. Description and Business Overview
6.15.3 WEIMEIZI (GUANGDONG) CO. Non-prescription Mouthrinse Sales, Revenue and Gross Margin (2020-2025)
6.15.4 WEIMEIZI (GUANGDONG) CO. Non-prescription Mouthrinse Product Portfolio
6.15.5 WEIMEIZI (GUANGDONG) CO. Recent Developments/Updates
6.16 Reckitt Benckiser Group Plc
6.16.1 Reckitt Benckiser Group Plc Company Information
6.16.2 Reckitt Benckiser Group Plc Description and Business Overview
6.16.3 Reckitt Benckiser Group Plc Non-prescription Mouthrinse Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Reckitt Benckiser Group Plc Non-prescription Mouthrinse Product Portfolio
6.16.5 Reckitt Benckiser Group Plc Recent Developments/Updates
6.17 SmartMouth Oral Health Laboratories
6.17.1 SmartMouth Oral Health Laboratories Company Information
6.17.2 SmartMouth Oral Health Laboratories Description and Business Overview
6.17.3 SmartMouth Oral Health Laboratories Non-prescription Mouthrinse Sales, Revenue and Gross Margin (2020-2025)
6.17.4 SmartMouth Oral Health Laboratories Non-prescription Mouthrinse Product Portfolio
6.17.5 SmartMouth Oral Health Laboratories Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Non-prescription Mouthrinse Industry Chain Analysis
7.2 Non-prescription Mouthrinse Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Non-prescription Mouthrinse Production Mode & Process Analysis
7.4 Non-prescription Mouthrinse Sales and Marketing
7.4.1 Non-prescription Mouthrinse Sales Channels
7.4.2 Non-prescription Mouthrinse Distributors
7.5 Non-prescription Mouthrinse Customer Analysis
8 Non-prescription Mouthrinse Market Dynamics
8.1 Non-prescription Mouthrinse Industry Trends
8.2 Non-prescription Mouthrinse Market Drivers
8.3 Non-prescription Mouthrinse Market Challenges
8.4 Non-prescription Mouthrinse Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Non-prescription Mouthrinse by Type
1.2.1 Global Non-prescription Mouthrinse Market Value Comparison by Type (2024 VS 2031)
1.2.2 Alcoholic
1.2.3 Non-alcoholic
1.3 Non-prescription Mouthrinse by Application
1.3.1 Global Non-prescription Mouthrinse Market Value by Application (2024 VS 2031)
1.3.2 Hypermarket and Supermarket
1.3.3 Convenience Stores
1.3.4 Online Sale
1.4 Global Non-prescription Mouthrinse Market Size Estimates and Forecasts
1.4.1 Global Non-prescription Mouthrinse Revenue 2020-2031
1.4.2 Global Non-prescription Mouthrinse Sales 2020-2031
1.4.3 Global Non-prescription Mouthrinse Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Non-prescription Mouthrinse Market Competition by Manufacturers
2.1 Global Non-prescription Mouthrinse Sales Market Share by Manufacturers (2020-2025)
2.2 Global Non-prescription Mouthrinse Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Non-prescription Mouthrinse Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Non-prescription Mouthrinse, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Non-prescription Mouthrinse, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Non-prescription Mouthrinse, Product Type & Application
2.7 Global Key Manufacturers of Non-prescription Mouthrinse, Date of Enter into This Industry
2.8 Global Non-prescription Mouthrinse Market Competitive Situation and Trends
2.8.1 Global Non-prescription Mouthrinse Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Non-prescription Mouthrinse Players Market Share by Revenue
2.8.3 Global Non-prescription Mouthrinse Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Non-prescription Mouthrinse Market Scenario by Region
3.1 Global Non-prescription Mouthrinse Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Non-prescription Mouthrinse Sales by Region: 2020-2031
3.2.1 Global Non-prescription Mouthrinse Sales by Region: 2020-2025
3.2.2 Global Non-prescription Mouthrinse Sales by Region: 2026-2031
3.3 Global Non-prescription Mouthrinse Revenue by Region: 2020-2031
3.3.1 Global Non-prescription Mouthrinse Revenue by Region: 2020-2025
3.3.2 Global Non-prescription Mouthrinse Revenue by Region: 2026-2031
3.4 North America Non-prescription Mouthrinse Market Facts & Figures by Country
3.4.1 North America Non-prescription Mouthrinse Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Non-prescription Mouthrinse Sales by Country (2020-2031)
3.4.3 North America Non-prescription Mouthrinse Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Non-prescription Mouthrinse Market Facts & Figures by Country
3.5.1 Europe Non-prescription Mouthrinse Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Non-prescription Mouthrinse Sales by Country (2020-2031)
3.5.3 Europe Non-prescription Mouthrinse Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Non-prescription Mouthrinse Market Facts & Figures by Region
3.6.1 Asia Pacific Non-prescription Mouthrinse Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Non-prescription Mouthrinse Sales by Region (2020-2031)
3.6.3 Asia Pacific Non-prescription Mouthrinse Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Non-prescription Mouthrinse Market Facts & Figures by Country
3.7.1 Latin America Non-prescription Mouthrinse Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Non-prescription Mouthrinse Sales by Country (2020-2031)
3.7.3 Latin America Non-prescription Mouthrinse Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Non-prescription Mouthrinse Market Facts & Figures by Country
3.8.1 Middle East and Africa Non-prescription Mouthrinse Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Non-prescription Mouthrinse Sales by Country (2020-2031)
3.8.3 Middle East and Africa Non-prescription Mouthrinse Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Non-prescription Mouthrinse Sales by Type (2020-2031)
4.1.1 Global Non-prescription Mouthrinse Sales by Type (2020-2025)
4.1.2 Global Non-prescription Mouthrinse Sales by Type (2026-2031)
4.1.3 Global Non-prescription Mouthrinse Sales Market Share by Type (2020-2031)
4.2 Global Non-prescription Mouthrinse Revenue by Type (2020-2031)
4.2.1 Global Non-prescription Mouthrinse Revenue by Type (2020-2025)
4.2.2 Global Non-prescription Mouthrinse Revenue by Type (2026-2031)
4.2.3 Global Non-prescription Mouthrinse Revenue Market Share by Type (2020-2031)
4.3 Global Non-prescription Mouthrinse Price by Type (2020-2031)
5 Segment by Application
5.1 Global Non-prescription Mouthrinse Sales by Application (2020-2031)
5.1.1 Global Non-prescription Mouthrinse Sales by Application (2020-2025)
5.1.2 Global Non-prescription Mouthrinse Sales by Application (2026-2031)
5.1.3 Global Non-prescription Mouthrinse Sales Market Share by Application (2020-2031)
5.2 Global Non-prescription Mouthrinse Revenue by Application (2020-2031)
5.2.1 Global Non-prescription Mouthrinse Revenue by Application (2020-2025)
5.2.2 Global Non-prescription Mouthrinse Revenue by Application (2026-2031)
5.2.3 Global Non-prescription Mouthrinse Revenue Market Share by Application (2020-2031)
5.3 Global Non-prescription Mouthrinse Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Johnson & Johnson
6.1.1 Johnson & Johnson Company Information
6.1.2 Johnson & Johnson Description and Business Overview
6.1.3 Johnson & Johnson Non-prescription Mouthrinse Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Johnson & Johnson Non-prescription Mouthrinse Product Portfolio
6.1.5 Johnson & Johnson Recent Developments/Updates
6.2 Sunstar
6.2.1 Sunstar Company Information
6.2.2 Sunstar Description and Business Overview
6.2.3 Sunstar Non-prescription Mouthrinse Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Sunstar Non-prescription Mouthrinse Product Portfolio
6.2.5 Sunstar Recent Developments/Updates
6.3 P&G
6.3.1 P&G Company Information
6.3.2 P&G Description and Business Overview
6.3.3 P&G Non-prescription Mouthrinse Sales, Revenue and Gross Margin (2020-2025)
6.3.4 P&G Non-prescription Mouthrinse Product Portfolio
6.3.5 P&G Recent Developments/Updates
6.4 Lion
6.4.1 Lion Company Information
6.4.2 Lion Description and Business Overview
6.4.3 Lion Non-prescription Mouthrinse Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Lion Non-prescription Mouthrinse Product Portfolio
6.4.5 Lion Recent Developments/Updates
6.5 Colgate-Palmolive
6.5.1 Colgate-Palmolive Company Information
6.5.2 Colgate-Palmolive Description and Business Overview
6.5.3 Colgate-Palmolive Non-prescription Mouthrinse Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Colgate-Palmolive Non-prescription Mouthrinse Product Portfolio
6.5.5 Colgate-Palmolive Recent Developments/Updates
6.6 Unilever
6.6.1 Unilever Company Information
6.6.2 Unilever Description and Business Overview
6.6.3 Unilever Non-prescription Mouthrinse Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Unilever Non-prescription Mouthrinse Product Portfolio
6.6.5 Unilever Recent Developments/Updates
6.7 Church & Dwight
6.7.1 Church & Dwight Company Information
6.7.2 Church & Dwight Description and Business Overview
6.7.3 Church & Dwight Non-prescription Mouthrinse Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Church & Dwight Non-prescription Mouthrinse Product Portfolio
6.7.5 Church & Dwight Recent Developments/Updates
6.8 PIERAS CO
6.8.1 PIERAS CO Company Information
6.8.2 PIERAS CO Description and Business Overview
6.8.3 PIERAS CO Non-prescription Mouthrinse Sales, Revenue and Gross Margin (2020-2025)
6.8.4 PIERAS CO Non-prescription Mouthrinse Product Portfolio
6.8.5 PIERAS CO Recent Developments/Updates
6.9 GSK
6.9.1 GSK Company Information
6.9.2 GSK Description and Business Overview
6.9.3 GSK Non-prescription Mouthrinse Sales, Revenue and Gross Margin (2020-2025)
6.9.4 GSK Non-prescription Mouthrinse Product Portfolio
6.9.5 GSK Recent Developments/Updates
6.10 Caldwell Consumer Health
6.10.1 Caldwell Consumer Health Company Information
6.10.2 Caldwell Consumer Health Description and Business Overview
6.10.3 Caldwell Consumer Health Non-prescription Mouthrinse Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Caldwell Consumer Health Non-prescription Mouthrinse Product Portfolio
6.10.5 Caldwell Consumer Health Recent Developments/Updates
6.11 Weleda
6.11.1 Weleda Company Information
6.11.2 Weleda Description and Business Overview
6.11.3 Weleda Non-prescription Mouthrinse Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Weleda Non-prescription Mouthrinse Product Portfolio
6.11.5 Weleda Recent Developments/Updates
6.12 Dentyl Active
6.12.1 Dentyl Active Company Information
6.12.2 Dentyl Active Description and Business Overview
6.12.3 Dentyl Active Non-prescription Mouthrinse Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Dentyl Active Non-prescription Mouthrinse Product Portfolio
6.12.5 Dentyl Active Recent Developments/Updates
6.13 Kao Corporation
6.13.1 Kao Corporation Company Information
6.13.2 Kao Corporation Description and Business Overview
6.13.3 Kao Corporation Non-prescription Mouthrinse Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Kao Corporation Non-prescription Mouthrinse Product Portfolio
6.13.5 Kao Corporation Recent Developments/Updates
6.14 NYSCPS
6.14.1 NYSCPS Company Information
6.14.2 NYSCPS Description and Business Overview
6.14.3 NYSCPS Non-prescription Mouthrinse Sales, Revenue and Gross Margin (2020-2025)
6.14.4 NYSCPS Non-prescription Mouthrinse Product Portfolio
6.14.5 NYSCPS Recent Developments/Updates
6.15 WEIMEIZI (GUANGDONG) CO.
6.15.1 WEIMEIZI (GUANGDONG) CO. Company Information
6.15.2 WEIMEIZI (GUANGDONG) CO. Description and Business Overview
6.15.3 WEIMEIZI (GUANGDONG) CO. Non-prescription Mouthrinse Sales, Revenue and Gross Margin (2020-2025)
6.15.4 WEIMEIZI (GUANGDONG) CO. Non-prescription Mouthrinse Product Portfolio
6.15.5 WEIMEIZI (GUANGDONG) CO. Recent Developments/Updates
6.16 Reckitt Benckiser Group Plc
6.16.1 Reckitt Benckiser Group Plc Company Information
6.16.2 Reckitt Benckiser Group Plc Description and Business Overview
6.16.3 Reckitt Benckiser Group Plc Non-prescription Mouthrinse Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Reckitt Benckiser Group Plc Non-prescription Mouthrinse Product Portfolio
6.16.5 Reckitt Benckiser Group Plc Recent Developments/Updates
6.17 SmartMouth Oral Health Laboratories
6.17.1 SmartMouth Oral Health Laboratories Company Information
6.17.2 SmartMouth Oral Health Laboratories Description and Business Overview
6.17.3 SmartMouth Oral Health Laboratories Non-prescription Mouthrinse Sales, Revenue and Gross Margin (2020-2025)
6.17.4 SmartMouth Oral Health Laboratories Non-prescription Mouthrinse Product Portfolio
6.17.5 SmartMouth Oral Health Laboratories Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Non-prescription Mouthrinse Industry Chain Analysis
7.2 Non-prescription Mouthrinse Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Non-prescription Mouthrinse Production Mode & Process Analysis
7.4 Non-prescription Mouthrinse Sales and Marketing
7.4.1 Non-prescription Mouthrinse Sales Channels
7.4.2 Non-prescription Mouthrinse Distributors
7.5 Non-prescription Mouthrinse Customer Analysis
8 Non-prescription Mouthrinse Market Dynamics
8.1 Non-prescription Mouthrinse Industry Trends
8.2 Non-prescription Mouthrinse Market Drivers
8.3 Non-prescription Mouthrinse Market Challenges
8.4 Non-prescription Mouthrinse Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Non-prescription Mouthrinse Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Non-prescription Mouthrinse Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Non-prescription Mouthrinse Market Competitive Situation by Manufacturers in 2024
Table 4. Global Non-prescription Mouthrinse Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Non-prescription Mouthrinse Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Non-prescription Mouthrinse Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Non-prescription Mouthrinse Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Non-prescription Mouthrinse Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Non-prescription Mouthrinse, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Non-prescription Mouthrinse, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Non-prescription Mouthrinse, Product Type & Application
Table 12. Global Key Manufacturers of Non-prescription Mouthrinse, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Non-prescription Mouthrinse by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-prescription Mouthrinse as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Non-prescription Mouthrinse Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Non-prescription Mouthrinse Sales by Region (2020-2025) & (K Units)
Table 18. Global Non-prescription Mouthrinse Sales Market Share by Region (2020-2025)
Table 19. Global Non-prescription Mouthrinse Sales by Region (2026-2031) & (K Units)
Table 20. Global Non-prescription Mouthrinse Sales Market Share by Region (2026-2031)
Table 21. Global Non-prescription Mouthrinse Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Non-prescription Mouthrinse Revenue Market Share by Region (2020-2025)
Table 23. Global Non-prescription Mouthrinse Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Non-prescription Mouthrinse Revenue Market Share by Region (2026-2031)
Table 25. North America Non-prescription Mouthrinse Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Non-prescription Mouthrinse Sales by Country (2020-2025) & (K Units)
Table 27. North America Non-prescription Mouthrinse Sales by Country (2026-2031) & (K Units)
Table 28. North America Non-prescription Mouthrinse Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Non-prescription Mouthrinse Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Non-prescription Mouthrinse Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Non-prescription Mouthrinse Sales by Country (2020-2025) & (K Units)
Table 32. Europe Non-prescription Mouthrinse Sales by Country (2026-2031) & (K Units)
Table 33. Europe Non-prescription Mouthrinse Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Non-prescription Mouthrinse Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Non-prescription Mouthrinse Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Non-prescription Mouthrinse Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Non-prescription Mouthrinse Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Non-prescription Mouthrinse Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Non-prescription Mouthrinse Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Non-prescription Mouthrinse Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Non-prescription Mouthrinse Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Non-prescription Mouthrinse Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Non-prescription Mouthrinse Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Non-prescription Mouthrinse Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Non-prescription Mouthrinse Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Non-prescription Mouthrinse Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Non-prescription Mouthrinse Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Non-prescription Mouthrinse Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Non-prescription Mouthrinse Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Non-prescription Mouthrinse Sales (K Units) by Type (2020-2025)
Table 51. Global Non-prescription Mouthrinse Sales (K Units) by Type (2026-2031)
Table 52. Global Non-prescription Mouthrinse Sales Market Share by Type (2020-2025)
Table 53. Global Non-prescription Mouthrinse Sales Market Share by Type (2026-2031)
Table 54. Global Non-prescription Mouthrinse Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Non-prescription Mouthrinse Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Non-prescription Mouthrinse Revenue Market Share by Type (2020-2025)
Table 57. Global Non-prescription Mouthrinse Revenue Market Share by Type (2026-2031)
Table 58. Global Non-prescription Mouthrinse Price (US$/Unit) by Type (2020-2025)
Table 59. Global Non-prescription Mouthrinse Price (US$/Unit) by Type (2026-2031)
Table 60. Global Non-prescription Mouthrinse Sales (K Units) by Application (2020-2025)
Table 61. Global Non-prescription Mouthrinse Sales (K Units) by Application (2026-2031)
Table 62. Global Non-prescription Mouthrinse Sales Market Share by Application (2020-2025)
Table 63. Global Non-prescription Mouthrinse Sales Market Share by Application (2026-2031)
Table 64. Global Non-prescription Mouthrinse Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Non-prescription Mouthrinse Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Non-prescription Mouthrinse Revenue Market Share by Application (2020-2025)
Table 67. Global Non-prescription Mouthrinse Revenue Market Share by Application (2026-2031)
Table 68. Global Non-prescription Mouthrinse Price (US$/Unit) by Application (2020-2025)
Table 69. Global Non-prescription Mouthrinse Price (US$/Unit) by Application (2026-2031)
Table 70. Johnson & Johnson Company Information
Table 71. Johnson & Johnson Description and Business Overview
Table 72. Johnson & Johnson Non-prescription Mouthrinse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Johnson & Johnson Non-prescription Mouthrinse Product
Table 74. Johnson & Johnson Recent Developments/Updates
Table 75. Sunstar Company Information
Table 76. Sunstar Description and Business Overview
Table 77. Sunstar Non-prescription Mouthrinse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Sunstar Non-prescription Mouthrinse Product
Table 79. Sunstar Recent Developments/Updates
Table 80. P&G Company Information
Table 81. P&G Description and Business Overview
Table 82. P&G Non-prescription Mouthrinse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. P&G Non-prescription Mouthrinse Product
Table 84. P&G Recent Developments/Updates
Table 85. Lion Company Information
Table 86. Lion Description and Business Overview
Table 87. Lion Non-prescription Mouthrinse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Lion Non-prescription Mouthrinse Product
Table 89. Lion Recent Developments/Updates
Table 90. Colgate-Palmolive Company Information
Table 91. Colgate-Palmolive Description and Business Overview
Table 92. Colgate-Palmolive Non-prescription Mouthrinse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Colgate-Palmolive Non-prescription Mouthrinse Product
Table 94. Colgate-Palmolive Recent Developments/Updates
Table 95. Unilever Company Information
Table 96. Unilever Description and Business Overview
Table 97. Unilever Non-prescription Mouthrinse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Unilever Non-prescription Mouthrinse Product
Table 99. Unilever Recent Developments/Updates
Table 100. Church & Dwight Company Information
Table 101. Church & Dwight Description and Business Overview
Table 102. Church & Dwight Non-prescription Mouthrinse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Church & Dwight Non-prescription Mouthrinse Product
Table 104. Church & Dwight Recent Developments/Updates
Table 105. PIERAS CO Company Information
Table 106. PIERAS CO Description and Business Overview
Table 107. PIERAS CO Non-prescription Mouthrinse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. PIERAS CO Non-prescription Mouthrinse Product
Table 109. PIERAS CO Recent Developments/Updates
Table 110. GSK Company Information
Table 111. GSK Description and Business Overview
Table 112. GSK Non-prescription Mouthrinse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. GSK Non-prescription Mouthrinse Product
Table 114. GSK Recent Developments/Updates
Table 115. Caldwell Consumer Health Company Information
Table 116. Caldwell Consumer Health Description and Business Overview
Table 117. Caldwell Consumer Health Non-prescription Mouthrinse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Caldwell Consumer Health Non-prescription Mouthrinse Product
Table 119. Caldwell Consumer Health Recent Developments/Updates
Table 120. Weleda Company Information
Table 121. Weleda Description and Business Overview
Table 122. Weleda Non-prescription Mouthrinse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Weleda Non-prescription Mouthrinse Product
Table 124. Weleda Recent Developments/Updates
Table 125. Dentyl Active Company Information
Table 126. Dentyl Active Description and Business Overview
Table 127. Dentyl Active Non-prescription Mouthrinse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Dentyl Active Non-prescription Mouthrinse Product
Table 129. Dentyl Active Recent Developments/Updates
Table 130. Kao Corporation Company Information
Table 131. Kao Corporation Description and Business Overview
Table 132. Kao Corporation Non-prescription Mouthrinse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Kao Corporation Non-prescription Mouthrinse Product
Table 134. Kao Corporation Recent Developments/Updates
Table 135. NYSCPS Company Information
Table 136. NYSCPS Description and Business Overview
Table 137. NYSCPS Non-prescription Mouthrinse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. NYSCPS Non-prescription Mouthrinse Product
Table 139. NYSCPS Recent Developments/Updates
Table 140. WEIMEIZI (GUANGDONG) CO. Company Information
Table 141. WEIMEIZI (GUANGDONG) CO. Description and Business Overview
Table 142. WEIMEIZI (GUANGDONG) CO. Non-prescription Mouthrinse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. WEIMEIZI (GUANGDONG) CO. Non-prescription Mouthrinse Product
Table 144. WEIMEIZI (GUANGDONG) CO. Recent Developments/Updates
Table 145. Reckitt Benckiser Group Plc Company Information
Table 146. Reckitt Benckiser Group Plc Description and Business Overview
Table 147. Reckitt Benckiser Group Plc Non-prescription Mouthrinse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Reckitt Benckiser Group Plc Non-prescription Mouthrinse Product
Table 149. Reckitt Benckiser Group Plc Recent Developments/Updates
Table 150. SmartMouth Oral Health Laboratories Company Information
Table 151. SmartMouth Oral Health Laboratories Description and Business Overview
Table 152. SmartMouth Oral Health Laboratories Non-prescription Mouthrinse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. SmartMouth Oral Health Laboratories Non-prescription Mouthrinse Product
Table 154. SmartMouth Oral Health Laboratories Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Non-prescription Mouthrinse Distributors List
Table 158. Non-prescription Mouthrinse Customers List
Table 159. Non-prescription Mouthrinse Market Trends
Table 160. Non-prescription Mouthrinse Market Drivers
Table 161. Non-prescription Mouthrinse Market Challenges
Table 162. Non-prescription Mouthrinse Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
Table 166. Authors List of This Report
List of Figures
Figure 1. Product Picture of Non-prescription Mouthrinse
Figure 2. Global Non-prescription Mouthrinse Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Non-prescription Mouthrinse Market Share by Type: 2024 & 2031
Figure 4. Alcoholic Product Picture
Figure 5. Non-alcoholic Product Picture
Figure 6. Global Non-prescription Mouthrinse Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Non-prescription Mouthrinse Market Share by Application: 2024 & 2031
Figure 8. Hypermarket and Supermarket
Figure 9. Convenience Stores
Figure 10. Online Sale
Figure 11. Global Non-prescription Mouthrinse Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Non-prescription Mouthrinse Market Size (2020-2031) & (US$ Million)
Figure 13. Global Non-prescription Mouthrinse Sales (2020-2031) & (K Units)
Figure 14. Global Non-prescription Mouthrinse Average Price (US$/Unit) & (2020-2031)
Figure 15. Non-prescription Mouthrinse Report Years Considered
Figure 16. Non-prescription Mouthrinse Sales Share by Manufacturers in 2024
Figure 17. Global Non-prescription Mouthrinse Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Non-prescription Mouthrinse Players: Market Share by Revenue in Non-prescription Mouthrinse in 2024
Figure 19. Non-prescription Mouthrinse Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Non-prescription Mouthrinse Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Non-prescription Mouthrinse Sales Market Share by Country (2020-2031)
Figure 22. North America Non-prescription Mouthrinse Revenue Market Share by Country (2020-2031)
Figure 23. U.S. Non-prescription Mouthrinse Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Non-prescription Mouthrinse Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Non-prescription Mouthrinse Sales Market Share by Country (2020-2031)
Figure 26. Europe Non-prescription Mouthrinse Revenue Market Share by Country (2020-2031)
Figure 27. Germany Non-prescription Mouthrinse Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Non-prescription Mouthrinse Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Non-prescription Mouthrinse Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Non-prescription Mouthrinse Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Non-prescription Mouthrinse Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Non-prescription Mouthrinse Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Non-prescription Mouthrinse Revenue Market Share by Region (2020-2031)
Figure 34. China Non-prescription Mouthrinse Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Non-prescription Mouthrinse Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Non-prescription Mouthrinse Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Non-prescription Mouthrinse Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Non-prescription Mouthrinse Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Taiwan Non-prescription Mouthrinse Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Indonesia Non-prescription Mouthrinse Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Thailand Non-prescription Mouthrinse Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Malaysia Non-prescription Mouthrinse Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Philippines Non-prescription Mouthrinse Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America Non-prescription Mouthrinse Sales Market Share by Country (2020-2031)
Figure 45. Latin America Non-prescription Mouthrinse Revenue Market Share by Country (2020-2031)
Figure 46. Mexico Non-prescription Mouthrinse Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil Non-prescription Mouthrinse Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina Non-prescription Mouthrinse Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa Non-prescription Mouthrinse Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Non-prescription Mouthrinse Revenue Market Share by Country (2020-2031)
Figure 51. Turkey Non-prescription Mouthrinse Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Non-prescription Mouthrinse Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. U.A.E Non-prescription Mouthrinse Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of Non-prescription Mouthrinse by Type (2020-2031)
Figure 55. Global Revenue Market Share of Non-prescription Mouthrinse by Type (2020-2031)
Figure 56. Global Non-prescription Mouthrinse Price (US$/Unit) by Type (2020-2031)
Figure 57. Global Sales Market Share of Non-prescription Mouthrinse by Application (2020-2031)
Figure 58. Global Revenue Market Share of Non-prescription Mouthrinse by Application (2020-2031)
Figure 59. Global Non-prescription Mouthrinse Price (US$/Unit) by Application (2020-2031)
Figure 60. Non-prescription Mouthrinse Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Table 1. Global Non-prescription Mouthrinse Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Non-prescription Mouthrinse Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Non-prescription Mouthrinse Market Competitive Situation by Manufacturers in 2024
Table 4. Global Non-prescription Mouthrinse Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Non-prescription Mouthrinse Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Non-prescription Mouthrinse Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Non-prescription Mouthrinse Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Non-prescription Mouthrinse Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Non-prescription Mouthrinse, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Non-prescription Mouthrinse, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Non-prescription Mouthrinse, Product Type & Application
Table 12. Global Key Manufacturers of Non-prescription Mouthrinse, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Non-prescription Mouthrinse by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-prescription Mouthrinse as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Non-prescription Mouthrinse Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Non-prescription Mouthrinse Sales by Region (2020-2025) & (K Units)
Table 18. Global Non-prescription Mouthrinse Sales Market Share by Region (2020-2025)
Table 19. Global Non-prescription Mouthrinse Sales by Region (2026-2031) & (K Units)
Table 20. Global Non-prescription Mouthrinse Sales Market Share by Region (2026-2031)
Table 21. Global Non-prescription Mouthrinse Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Non-prescription Mouthrinse Revenue Market Share by Region (2020-2025)
Table 23. Global Non-prescription Mouthrinse Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Non-prescription Mouthrinse Revenue Market Share by Region (2026-2031)
Table 25. North America Non-prescription Mouthrinse Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Non-prescription Mouthrinse Sales by Country (2020-2025) & (K Units)
Table 27. North America Non-prescription Mouthrinse Sales by Country (2026-2031) & (K Units)
Table 28. North America Non-prescription Mouthrinse Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Non-prescription Mouthrinse Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Non-prescription Mouthrinse Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Non-prescription Mouthrinse Sales by Country (2020-2025) & (K Units)
Table 32. Europe Non-prescription Mouthrinse Sales by Country (2026-2031) & (K Units)
Table 33. Europe Non-prescription Mouthrinse Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Non-prescription Mouthrinse Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Non-prescription Mouthrinse Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Non-prescription Mouthrinse Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Non-prescription Mouthrinse Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Non-prescription Mouthrinse Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Non-prescription Mouthrinse Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Non-prescription Mouthrinse Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Non-prescription Mouthrinse Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Non-prescription Mouthrinse Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Non-prescription Mouthrinse Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Non-prescription Mouthrinse Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Non-prescription Mouthrinse Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Non-prescription Mouthrinse Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Non-prescription Mouthrinse Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Non-prescription Mouthrinse Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Non-prescription Mouthrinse Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Non-prescription Mouthrinse Sales (K Units) by Type (2020-2025)
Table 51. Global Non-prescription Mouthrinse Sales (K Units) by Type (2026-2031)
Table 52. Global Non-prescription Mouthrinse Sales Market Share by Type (2020-2025)
Table 53. Global Non-prescription Mouthrinse Sales Market Share by Type (2026-2031)
Table 54. Global Non-prescription Mouthrinse Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Non-prescription Mouthrinse Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Non-prescription Mouthrinse Revenue Market Share by Type (2020-2025)
Table 57. Global Non-prescription Mouthrinse Revenue Market Share by Type (2026-2031)
Table 58. Global Non-prescription Mouthrinse Price (US$/Unit) by Type (2020-2025)
Table 59. Global Non-prescription Mouthrinse Price (US$/Unit) by Type (2026-2031)
Table 60. Global Non-prescription Mouthrinse Sales (K Units) by Application (2020-2025)
Table 61. Global Non-prescription Mouthrinse Sales (K Units) by Application (2026-2031)
Table 62. Global Non-prescription Mouthrinse Sales Market Share by Application (2020-2025)
Table 63. Global Non-prescription Mouthrinse Sales Market Share by Application (2026-2031)
Table 64. Global Non-prescription Mouthrinse Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Non-prescription Mouthrinse Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Non-prescription Mouthrinse Revenue Market Share by Application (2020-2025)
Table 67. Global Non-prescription Mouthrinse Revenue Market Share by Application (2026-2031)
Table 68. Global Non-prescription Mouthrinse Price (US$/Unit) by Application (2020-2025)
Table 69. Global Non-prescription Mouthrinse Price (US$/Unit) by Application (2026-2031)
Table 70. Johnson & Johnson Company Information
Table 71. Johnson & Johnson Description and Business Overview
Table 72. Johnson & Johnson Non-prescription Mouthrinse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Johnson & Johnson Non-prescription Mouthrinse Product
Table 74. Johnson & Johnson Recent Developments/Updates
Table 75. Sunstar Company Information
Table 76. Sunstar Description and Business Overview
Table 77. Sunstar Non-prescription Mouthrinse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Sunstar Non-prescription Mouthrinse Product
Table 79. Sunstar Recent Developments/Updates
Table 80. P&G Company Information
Table 81. P&G Description and Business Overview
Table 82. P&G Non-prescription Mouthrinse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. P&G Non-prescription Mouthrinse Product
Table 84. P&G Recent Developments/Updates
Table 85. Lion Company Information
Table 86. Lion Description and Business Overview
Table 87. Lion Non-prescription Mouthrinse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Lion Non-prescription Mouthrinse Product
Table 89. Lion Recent Developments/Updates
Table 90. Colgate-Palmolive Company Information
Table 91. Colgate-Palmolive Description and Business Overview
Table 92. Colgate-Palmolive Non-prescription Mouthrinse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Colgate-Palmolive Non-prescription Mouthrinse Product
Table 94. Colgate-Palmolive Recent Developments/Updates
Table 95. Unilever Company Information
Table 96. Unilever Description and Business Overview
Table 97. Unilever Non-prescription Mouthrinse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Unilever Non-prescription Mouthrinse Product
Table 99. Unilever Recent Developments/Updates
Table 100. Church & Dwight Company Information
Table 101. Church & Dwight Description and Business Overview
Table 102. Church & Dwight Non-prescription Mouthrinse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Church & Dwight Non-prescription Mouthrinse Product
Table 104. Church & Dwight Recent Developments/Updates
Table 105. PIERAS CO Company Information
Table 106. PIERAS CO Description and Business Overview
Table 107. PIERAS CO Non-prescription Mouthrinse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. PIERAS CO Non-prescription Mouthrinse Product
Table 109. PIERAS CO Recent Developments/Updates
Table 110. GSK Company Information
Table 111. GSK Description and Business Overview
Table 112. GSK Non-prescription Mouthrinse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. GSK Non-prescription Mouthrinse Product
Table 114. GSK Recent Developments/Updates
Table 115. Caldwell Consumer Health Company Information
Table 116. Caldwell Consumer Health Description and Business Overview
Table 117. Caldwell Consumer Health Non-prescription Mouthrinse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Caldwell Consumer Health Non-prescription Mouthrinse Product
Table 119. Caldwell Consumer Health Recent Developments/Updates
Table 120. Weleda Company Information
Table 121. Weleda Description and Business Overview
Table 122. Weleda Non-prescription Mouthrinse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Weleda Non-prescription Mouthrinse Product
Table 124. Weleda Recent Developments/Updates
Table 125. Dentyl Active Company Information
Table 126. Dentyl Active Description and Business Overview
Table 127. Dentyl Active Non-prescription Mouthrinse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Dentyl Active Non-prescription Mouthrinse Product
Table 129. Dentyl Active Recent Developments/Updates
Table 130. Kao Corporation Company Information
Table 131. Kao Corporation Description and Business Overview
Table 132. Kao Corporation Non-prescription Mouthrinse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Kao Corporation Non-prescription Mouthrinse Product
Table 134. Kao Corporation Recent Developments/Updates
Table 135. NYSCPS Company Information
Table 136. NYSCPS Description and Business Overview
Table 137. NYSCPS Non-prescription Mouthrinse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. NYSCPS Non-prescription Mouthrinse Product
Table 139. NYSCPS Recent Developments/Updates
Table 140. WEIMEIZI (GUANGDONG) CO. Company Information
Table 141. WEIMEIZI (GUANGDONG) CO. Description and Business Overview
Table 142. WEIMEIZI (GUANGDONG) CO. Non-prescription Mouthrinse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. WEIMEIZI (GUANGDONG) CO. Non-prescription Mouthrinse Product
Table 144. WEIMEIZI (GUANGDONG) CO. Recent Developments/Updates
Table 145. Reckitt Benckiser Group Plc Company Information
Table 146. Reckitt Benckiser Group Plc Description and Business Overview
Table 147. Reckitt Benckiser Group Plc Non-prescription Mouthrinse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Reckitt Benckiser Group Plc Non-prescription Mouthrinse Product
Table 149. Reckitt Benckiser Group Plc Recent Developments/Updates
Table 150. SmartMouth Oral Health Laboratories Company Information
Table 151. SmartMouth Oral Health Laboratories Description and Business Overview
Table 152. SmartMouth Oral Health Laboratories Non-prescription Mouthrinse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. SmartMouth Oral Health Laboratories Non-prescription Mouthrinse Product
Table 154. SmartMouth Oral Health Laboratories Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Non-prescription Mouthrinse Distributors List
Table 158. Non-prescription Mouthrinse Customers List
Table 159. Non-prescription Mouthrinse Market Trends
Table 160. Non-prescription Mouthrinse Market Drivers
Table 161. Non-prescription Mouthrinse Market Challenges
Table 162. Non-prescription Mouthrinse Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
Table 166. Authors List of This Report
List of Figures
Figure 1. Product Picture of Non-prescription Mouthrinse
Figure 2. Global Non-prescription Mouthrinse Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Non-prescription Mouthrinse Market Share by Type: 2024 & 2031
Figure 4. Alcoholic Product Picture
Figure 5. Non-alcoholic Product Picture
Figure 6. Global Non-prescription Mouthrinse Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Non-prescription Mouthrinse Market Share by Application: 2024 & 2031
Figure 8. Hypermarket and Supermarket
Figure 9. Convenience Stores
Figure 10. Online Sale
Figure 11. Global Non-prescription Mouthrinse Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Non-prescription Mouthrinse Market Size (2020-2031) & (US$ Million)
Figure 13. Global Non-prescription Mouthrinse Sales (2020-2031) & (K Units)
Figure 14. Global Non-prescription Mouthrinse Average Price (US$/Unit) & (2020-2031)
Figure 15. Non-prescription Mouthrinse Report Years Considered
Figure 16. Non-prescription Mouthrinse Sales Share by Manufacturers in 2024
Figure 17. Global Non-prescription Mouthrinse Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Non-prescription Mouthrinse Players: Market Share by Revenue in Non-prescription Mouthrinse in 2024
Figure 19. Non-prescription Mouthrinse Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Non-prescription Mouthrinse Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Non-prescription Mouthrinse Sales Market Share by Country (2020-2031)
Figure 22. North America Non-prescription Mouthrinse Revenue Market Share by Country (2020-2031)
Figure 23. U.S. Non-prescription Mouthrinse Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Non-prescription Mouthrinse Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Non-prescription Mouthrinse Sales Market Share by Country (2020-2031)
Figure 26. Europe Non-prescription Mouthrinse Revenue Market Share by Country (2020-2031)
Figure 27. Germany Non-prescription Mouthrinse Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Non-prescription Mouthrinse Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Non-prescription Mouthrinse Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Non-prescription Mouthrinse Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Non-prescription Mouthrinse Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Non-prescription Mouthrinse Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Non-prescription Mouthrinse Revenue Market Share by Region (2020-2031)
Figure 34. China Non-prescription Mouthrinse Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Non-prescription Mouthrinse Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Non-prescription Mouthrinse Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Non-prescription Mouthrinse Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Non-prescription Mouthrinse Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Taiwan Non-prescription Mouthrinse Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Indonesia Non-prescription Mouthrinse Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Thailand Non-prescription Mouthrinse Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Malaysia Non-prescription Mouthrinse Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Philippines Non-prescription Mouthrinse Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America Non-prescription Mouthrinse Sales Market Share by Country (2020-2031)
Figure 45. Latin America Non-prescription Mouthrinse Revenue Market Share by Country (2020-2031)
Figure 46. Mexico Non-prescription Mouthrinse Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil Non-prescription Mouthrinse Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina Non-prescription Mouthrinse Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa Non-prescription Mouthrinse Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Non-prescription Mouthrinse Revenue Market Share by Country (2020-2031)
Figure 51. Turkey Non-prescription Mouthrinse Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Non-prescription Mouthrinse Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. U.A.E Non-prescription Mouthrinse Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of Non-prescription Mouthrinse by Type (2020-2031)
Figure 55. Global Revenue Market Share of Non-prescription Mouthrinse by Type (2020-2031)
Figure 56. Global Non-prescription Mouthrinse Price (US$/Unit) by Type (2020-2031)
Figure 57. Global Sales Market Share of Non-prescription Mouthrinse by Application (2020-2031)
Figure 58. Global Revenue Market Share of Non-prescription Mouthrinse by Application (2020-2031)
Figure 59. Global Non-prescription Mouthrinse Price (US$/Unit) by Application (2020-2031)
Figure 60. Non-prescription Mouthrinse Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Pediatric Latex Double Hole Nasal Cannula Market Research Report 2025
May 16, 25
Global Pediatric Two-hole Nasal Cannula Market Research Report 2025
May 16, 25
Global Pediatric Nasal Oxygen Mask Market Research Report 2025
May 16, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232